Outcome
|
Severity
at enrollmentd
|
Positive at age 3
N (%)
|
HRe (95% CI)
|
p-Value
|
AD persistence |
AD persistence |
AD persistence |
AD persistence |
AD
persistence |
|
Mild |
39/72 (54.2) |
0.96 (0.84 − 1.09) |
0.495 |
|
Moderate |
41/61 (67.1) |
1.23 (1.07 − 1.40)
|
0.003 |
|
Severe |
16/17 (94.1) |
1.67 (1.16 − 2.41)
|
0.006 |
Allergen sensitization |
Allergen sensitization |
Allergen sensitization |
Allergen sensitization |
Allergen sensitization |
HDMa
|
Mild |
37/72 (51.4) |
0.99 (0.86 − 1.14) |
0.914 |
|
Moderate |
29/61 (47.5) |
1.13 (0.97 − 1.30) |
0.107 |
|
Severe |
13/17 (76.5) |
1.45 (0.98 − 2.13) |
0.058 |
Pollenb
|
Mild |
23/72 (31.9) |
1.07 (0.88 − 1.31) |
0.511 |
|
Moderate |
23/61 (37.7) |
1.33 (1.10 − 1.61)
|
0.003 |
|
Severe |
7/17 (41.2) |
NA |
NA |
Petc
|
Mild |
17/72 (23.6) |
0.94 (0.76 − 1.16) |
0.561 |
|
Moderate |
13/61 (21.3) |
1.06 (0.82 − 1.37) |
0.660 |
|
Severe |
5/17 (29.4) |
NA |
NA |